| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/11/2002 | US6403786 Compounds used to label, detect and sequence nucleic acids |
| 06/11/2002 | US6403778 Toxicological response markers |
| 06/11/2002 | US6403637 Administering 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase inhibitors to increase endocytosis of collagenase-3; used to treat arthritis and other degenerative joint diseases |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
| 06/11/2002 | US6403381 Using chelate compound |
| 06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
| 06/11/2002 | US6403373 Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these |
| 06/11/2002 | US6403367 Integrated portable biological detection system |
| 06/11/2002 | US6403360 Isolated nucleic acids |
| 06/11/2002 | US6403341 Magnesium precipitate hot start method for PCR |
| 06/11/2002 | US6403340 Template chain reaction |
| 06/11/2002 | US6403339 Method for detecting a nucleotide sequence |
| 06/11/2002 | US6403338 Fluid flowing sample containing nucleic acid into microscale chamber; amplification of plurality of sequences; detecting polymorphisms; dna sequencing |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403333 Method for determining the existence of a biological activity of microorganisms |
| 06/11/2002 | US6403329 Methods of detecting methylphosphonic compounds |
| 06/11/2002 | US6403327 Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears |
| 06/11/2002 | US6403321 Positioning polymer string between electrodes; applying voltage; semiconductor chips |
| 06/11/2002 | US6403320 Support bound probes and methods of analysis using the same |
| 06/11/2002 | US6403319 Mixing nucleic acid samples with hairpin primers; incubation, amplification, hybridization, and detection; sequence determination, genetic engineering |
| 06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
| 06/11/2002 | US6403317 Electronic detection of hybridization on nucleic acid arrays |
| 06/11/2002 | US6403316 Isolation of cDNA encoding for secreted or membranal proteins |
| 06/11/2002 | US6403315 Sequencing by hybridization; exposing array of probes and target nucleic acid with labeled probe; discriminating between full complementarity and one base mismatch; covalently bonding; analzying |
| 06/11/2002 | US6403314 Computational method and system for predicting fragmented hybridization and for identifying potential cross-hybridization |
| 06/11/2002 | US6403313 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators |
| 06/11/2002 | US6403311 Methods of analyzing polymers using ordered label strategies |
| 06/11/2002 | US6403309 High throughput assay; hybridization of probes; detecting signals from solid phase; removal of mismatched base parts with enzymes |
| 06/11/2002 | US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation |
| 06/11/2002 | US6403303 Method and reagents for testing for mutations in the BRCA1 gene |
| 06/11/2002 | US6403302 Methods and compositions for triple helix formation |
| 06/11/2002 | US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering |
| 06/11/2002 | US6403103 Cytoplasmic protein fragment selected from: the amino acid sequence from residue 402 to residue 426 of seq id no: 2; and an immunogenic fragment of said amino acid sequence comprising at least residue 408 to residue 417 of said amino acid |
| 06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6401267 Hybridization with two sets of small oligonucleotide probes of known sequences; chromosomes and non-amplified rna may be sequenced without prior cloning or subcloning steps. |
| 06/11/2002 | CA2329858A1 Expression cloning of protein targets for phospholipids |
| 06/11/2002 | CA2222556C Adduct protection assay |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2073186C Gene deleted in colorectal cancer in humans |
| 06/11/2002 | CA1341366C Molecular clones of the genome of htlv-iii |
| 06/08/2002 | CA2375097A1 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 06/08/2002 | CA2364324A1 Detecting reagent for double-stranded nucleic acid and double-stranded nucleic acid detecting method |
| 06/06/2002 | WO2002045323A2 Data relationship model |
| 06/06/2002 | WO2002044967A1 Method and system for providing gene analysis information and authentication identification method |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044735A1 Novel method for screening bacterial transcription modulators |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044733A2 Methods and compositions for sorting and/or determining microorganisms |
| 06/06/2002 | WO2002044720A2 Membrane molecule indicator compositions and methods |
| 06/06/2002 | WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof |
| 06/06/2002 | WO2002044715A1 Methods for efficiently minig broad data sets for biological markers |
| 06/06/2002 | WO2002044714A2 System and method for integrated analysis of data for characterizing carbohydrate polymers |
| 06/06/2002 | WO2002044713A2 Flow through device for two dimensional incubation and/or hybridization on solid supports |
| 06/06/2002 | WO2002044427A2 Cell based triple readout assay systems for identifying compounds that effect transcription |
| 06/06/2002 | WO2002044426A2 Nod2 nucleic acids and proteins |
| 06/06/2002 | WO2002044425A2 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| 06/06/2002 | WO2002044424A1 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer |
| 06/06/2002 | WO2002044423A2 Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
| 06/06/2002 | WO2002044422A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 06/06/2002 | WO2002044420A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044417A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | WO2002044414A2 Purification of dna sequencing reactions using silica magnetic particles |
| 06/06/2002 | WO2002044413A2 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
| 06/06/2002 | WO2002044412A1 Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interactions |
| 06/06/2002 | WO2002044411A1 Use of profiling for detecting aneuploidy |
| 06/06/2002 | WO2002044410A1 Drug target isogenes: polymorphisms in the interleukin 3 (colony-stimulating factor, multiple) gene |
| 06/06/2002 | WO2002044409A2 Substrate linked directed evolution (slide) |
| 06/06/2002 | WO2002044408A2 A method for identifying enzyme inhibitors |
| 06/06/2002 | WO2002044407A2 Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044405A2 Method and kit for the direct identification of nucleotide sequences, amino acid sequences or antigens |
| 06/06/2002 | WO2002044404A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 06/06/2002 | WO2002044403A2 Markers for testing analogs of vitamin d and therapeutical uses |
| 06/06/2002 | WO2002044402A1 Screening method |
| 06/06/2002 | WO2002044401A2 Process for detecting low abundance rna in intact cells |
| 06/06/2002 | WO2002044399A2 In vitro transcription method for rna amplification |
| 06/06/2002 | WO2002044398A2 Universal supports for oligonucleotide synthesis |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044361A2 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044339A2 Nucleic acid amplification methods |
| 06/06/2002 | WO2002044335A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 06/06/2002 | WO2002044326A2 Methods for detection of a target nucleic acid by capture |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |